THURSDAY, Nov. 7, 2024 (HealthDay News) -- The head of the company that makes the diabetes and obesity drugs Ozempic and ...

Ozempic, known generically as semaglutide, is an injectable prescription drug. It was approved in 2017 by the United States ...

The ‘Ozempic drug,’ semaglutide, has been found to reduce moderately severe pain caused by knee osteoarthritis and improve ...

Novo Nordisk’s CEO has alerted healthcare professionals about the growing risks associated with compounded semaglutide, a ...

Semaglutide, the active ingredient in Ozempic, has shown promising results in weight loss and blood sugar management. But did ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

Five University of Cambridge experts have shared their views on whether semaglutide-based drugs like Wegovy and Ozempic can ...

Researchers are weighing the effects of popular weight-loss medications like Ozempic on muscle mass. New work is "calling ...

Novo Nordisk addresses safety concerns surrounding compounded versions of its weight-loss and diabetes drugs, including ...

Right now what is opening up is Liraglutide, which represents about $3 billion of that total. Most of the market has shifted ...

U.S. Customs and Border Protection officers in Cincinnati recently seized more shipments containing unapproved medications.

But here’s the twist: Ozempic is just the flashy name. What you really want is semaglutide, the active ingredient doing all the heavy lifting. And guess what? You don’t have to go through the usual ...